Gerd
202
23
28
109
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
24 trials with published results (12%)
Research Maturity
109 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.9%
20 terminated out of 202 trials
84.5%
-2.0% vs benchmark
19%
38 trials in Phase 3/4
22%
24 of 109 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 109 completed trials
Clinical Trials (202)
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
PROPER-GERD: A Prospective Crossover Study to Evaluate Probe Placement Optimization for Reflux Testing in Women and Lower-BMI Patients
Alginate vs Sucralfate for GERD Symptomatic Relief
The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
Antireflux Surgery Without Preoperative Esophageal Manometry
Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy
A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
Pre- and Post-Therapy Evaluation of Air-Associated Symptoms in Patients With Gastro-esophageal Reflux Disease (GERD): Assessing the Role of Speech and Language Therapy
Effect of Obesity on Proton Pump Inhibitors
Famotidine and Antacids for Treatment of Dyspepsia
EndoStim Patient Registry
Transoral Incisional Fundoplication (TIF) for Patients Suffering From Gastroesophageal Reflux Disease in an Asian Population
Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM
Diaphragmatic Training on GERD
PRospective Registry of Esophageal Motility
Compassionate Use of Domperidone for Refractory Gastroparesis
A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
Mechanisms Preventing Pharyngeal Reflux
Minimally Invasive Surgery of the Gastro-esophageal Junction